ADHD: Vyvanse Capsules CII Administration Through 2 Routes Demonstrated Similar Pharmacokinetic Profile

Links shared publicly online about this topic.

  • 1,654
    total visits

ADHD: Vyvanse Capsules CII Administration Through 2 Routes Demonstrated Similar Pharmacokinetic Profile

medicalnewstoday.com —

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication

View full resource at medicalnewstoday.com

Tags: ADHD, ADHD Medication, Disease and Condition, Drug, Vyvanse, Pharmacokinetics, Shire

  • Share

Most Recently Shared on October 24, 2009 at 12:32 pm By:

mnt_clinical MNT Clinical Trials

ADHD: Vyvanse Capsules CII Administration Through 2 Routes Demonstrated Similar Pharmacokinetic Profile: Shire .. http://bit.ly/joZLL

3 years ago...

Reply

Retweet

Favorite

Also Shared By:

psychiatryrounds psychiatryrounds

Advertisement